sr 95531 has been researched along with Glaucoma, Suspect in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Li, G; Wu, J; Yang, B; Zhang, R; Zhang, S; Zhou, X | 1 |
1 other study(ies) available for sr 95531 and Glaucoma, Suspect
| Article | Year |
|---|---|
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzamides; Bridged Bicyclo Compounds; Cell Survival; Chronic Disease; Color Vision; Disease Models, Animal; Down-Regulation; GABA Antagonists; GABAergic Neurons; gamma-Aminobutyric Acid; Glaucoma; Glutamate Decarboxylase; Inhibitory Postsynaptic Potentials; Kinetics; Male; Models, Biological; Neuroprotective Agents; Ocular Hypertension; Presynaptic Terminals; Pyridazines; Rats, Wistar; Retinal Ganglion Cells | 2017 |